Trial intelligence / Profile preview

Liraglutide and LSG for Obesity

NCT04325581Phase 3Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
Aug 2016
Primary completion
Dec 2018
Modality
Peptides
01

Overview

A Phase 3 trial of liraglutide in obesity, sponsored by Post Graduate Institute of Medical Education and Research. Started Aug 2016; status: completed.

02

Drugs

03

Conditions

obesity

Beyond the preview

Go deeper on NCT04325581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04325581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call